Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist

Compiled from ClinicalTrials.gov and CTIS registry records · Last verified 26 Sep 2026 · Editorial standards

At a glance

Huashan Hospital is the lead sponsor of 75 current clinical trials in our China register. 55 are recruiting patients now. The most common phase is Observational. The drugs named most often in its trials are Tumor vaccine, Atezolizumab and Bedaquiline. The most-studied condition is Glioma.

ClinicalTrials.gov trials by status

Recruiting5573%
Not yet open1317%
Active, closed45%
By invitation34%

Trials by phase

Observational3445%
Not applicable1723%
Phase 2811%
Phase 368%
Phase EARLY_PHASE145%
Phase 445%
Phase 2/323%

Clinical trials sponsored by Huashan Hospital

75 on ClinicalTrials.gov

Study	Phase	Status	Start	Registers
Real World Study of End-stage Liver Disease in China NCT04037995 · End Stage Liver DIsease, Complication	Observational	Recruiting	2019-09	China
Hemorrhagic Brainstem Cavernous Malformations Treatment With Sirolimus: aSingle Centre, Randomized, Placebo-controlled Pilot Trial NCT06091332 · Cavernous Malformations, Intracerebral Hemorrhage, Brainstem Stroke Drug: Sirolimus	Phase 2	Recruiting	2024-01	China
Efficacy and Safety of Spinal Cord Stimulation in Patients With Spinal Cord Stimulation NCT06515132 · ClinicalTrials.gov ↗ · Disorder of Consciousness, Spinal Cord Stimulation	Not applicable	Recruiting	2025-01	China
Promotion and Application of a New Three-level Etiological Diagnosis Strategy for Fever Clinics in Respiratory Infectious Diseases NCT05965128 · ClinicalTrials.gov ↗ · Respiratory Infectious Diseases	Observational	Recruiting	2022-12	China
Efficacy and Safety of Human Urinary Kallidinogenase Combined With Endovascular Therapy in Acute Ischemic Stroke With Large Vessel Occlusion NCT06211712 · ClinicalTrials.gov ↗ · Acute Ischemic Stroke	Not applicable	Recruiting	2024-04	China
Application of a New Surgical Technique in Proximal Gastrectomy: a Prospective, Multicenter Randomized Controlled Study NCT06679244 · ClinicalTrials.gov ↗ · Gastric Cancer Patients Undergoing Minimally Invasive Gastrectomy	Not applicable	Recruiting	2024-12	China
Clinical Safety and Efficacy of Flow-diverter in the Treatment of Intracranial Aneurysms NCT06943729 · ClinicalTrials.gov ↗ · Flow Diverter	Observational	Recruiting	2025-04	China
Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of Drug-sensitive Tuberculosis(T) NCT05401071 · ClinicalTrials.gov ↗ · Tuberculosis, Pulmonary	Phase 2/3	Recruiting	2023-01	China
Sequential PEG-IFN for HBV After Ending RNA-targeted Regimens NCT06923280 · ClinicalTrials.gov ↗ · Hepatitis B, Chronic	Not applicable	Recruiting	2025-08	China
Bilateral Single-Electrode VO Combined With STN-DBS for Treating Meige Syndrome NCT06912282 · ClinicalTrials.gov ↗ · Meige Syndrome	Not applicable	Recruiting	2025-03	China
The Effectiveness and Safety of Body Posture in Preventing Postoperative Recurrence for Chronic Subdural Hematoma NCT06401772 · ClinicalTrials.gov ↗ · Chronic Subdural Hematoma, Recurrence	Not applicable	Recruiting	2024-08	China
A Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled IR199 in Patients With Gastric Cancer and Pancreatic Cancer NCT07707531 · ClinicalTrials.gov ↗ · Gastric Cancer, Pancreatic Cancer	Phase EARLY_PHASE1	Recruiting	2026-06	China
PDO Based Drug Sensitive Test in R/M HNSCC NCT06686342 · ClinicalTrials.gov ↗ · Head and Neck Squamous Cell Carcinoma, Patient Derived Organoid, Drug Sensitive Test in Vitro	Observational	Recruiting	2025-03	China
Construction of A Multimodal Digital Assessment Model for Myasthenia Gravis NCT07146425 · ClinicalTrials.gov ↗ · Myasthenia Gravis	Observational	Recruiting	2023-08	China
The Role of B7-H4 in Tumor Vaccine NCT06156150 · ClinicalTrials.gov ↗ · Glioma Drug: Tumor vaccine	Observational	Recruiting	2023-11	China
Orelabrutinib Combined With Teniposide, Rituximab and Methotrexate for Newly Diagnosed PCNSL NCT07185373 · ClinicalTrials.gov ↗ · Primary Central Nervous System Lymphoma Drugs: Dexamethasone, Orelabrutinib, Rituximab	Phase 2/3	Recruiting	2025-10	China
The Use of Propranolol in the Perioperative Period of Resectable Gastrointestinal Tumors NCT06775080 · ClinicalTrials.gov ↗ · Gastrointestinal Tumors	Phase 2	Recruiting	2024-12	China
Evaluating Safety, Tolerability, and Preliminary Efficacy of YSCH-01 Monotherapy and in Combination With Atezolizumab for Recurrent Glioblastoma NCT07538128 · ClinicalTrials.gov ↗ · Recurrent Glioblastoma Drugs: Atezolizumab, YSCH-01	Phase EARLY_PHASE1	Recruiting	2025-01	China
Study on the Effectiveness and Safety of Temporal Interference Stimulation in Treating Patients With Severe Consciousness Disorders NCT06896279 · ClinicalTrials.gov ↗ · Disorder of Consciousness, Temporal Interference Stimulation	Not applicable	Recruiting	2025-04	China
A Novel Therapy With a 1-Month Ultrashort Regimen to Halt Progression From Latent Infection to Active Tuberculosis Among Close Contacts (The TB-YOUTH Study) NCT06022146 · ClinicalTrials.gov ↗ · Tuberculosis, Latent Tuberculosis	Phase 3	Recruiting	2023-09	China
Tumor Vaccines for Solid Tumors NCT06102837 · ClinicalTrials.gov ↗ · Glioma, Solid Tumor Drug: Tumor vaccine	Observational	Recruiting	2023-10	China
Niaoduqing Granules in Older Adults With Impaired Kidney Function NCT07741292 · ClinicalTrials.gov ↗ · Chronic Kidney Disease	Phase 4	Recruiting	2025-12	China
Establishment of the Chinese Preclinical Alzheimer's Disease Study With Multiple Neuroimaging NCT06827678 · ClinicalTrials.gov ↗ · Alzheimer Disease, Positron Emission Tomography	Observational	Recruiting	2022-08	China
Precision Diagnosis and Prospective Cohort Study for Myasthenia Gravis: Multicenter Analysis in China NCT04535843 · ClinicalTrials.gov ↗ · Myasthenia Gravis	Observational	Recruiting	2024-02	China
SGLT2i Improve Left Atrial Function in Patients With Paroxysmal Atrial Fibrillation, Hypertension and Abnormal Glucose Metabolism NCT07482020 · ClinicalTrials.gov ↗ · Atrial Fibrillation (AF), Hypertension	Phase 2	Recruiting	2025-03	China
Colchicine for the Prevention of Recurrence in Cerebral Amyloid Angiopathy RElated IntraCerebral Hemorrhage NCT07026994 · ClinicalTrials.gov ↗ · Cerebral Amyloid Angiopathy, Intracerebral Hemorrhage Lobar	Phase 2	Recruiting	2025-06	China
Neoadjuvant of Sintilimab Combined Weekly Metronomic Chemotherapy (PLOF) for Resectable Locally Advanced Gastric Cancer NCT06054906 · ClinicalTrials.gov ↗ · Gastric Cancer Drug: Sintilimab	Phase 2	Recruiting	2023-10	China
Exploring the Application Efficacy of Artificial Intelligence (AI) Diagnostic Tools in Medical Imaging (MI) of Respiratory(R) Infectious (I) Disease (D) NCT06553911 · ClinicalTrials.gov ↗ · Respiratory Infectious Diseases, Artificial Intelligence, Medical Imaging	Not applicable	Recruiting	2022-04	China
HANDLE-a Real World Study on Satralizumab in NMOSD NCT06829524 · ClinicalTrials.gov ↗ · Neuromyelitis Optica Spectrum Disorders (NMOSD) Drug: Satralizumab	Observational	Recruiting	2025-03	China
Asymptomatic TB With Innovative Modified Short-course Regimens NCT06153069 · ClinicalTrials.gov ↗ · Tuberculosis	Phase 4	Recruiting	2025-11	China
Evaluation of Two Cell-based Assays for Diagnosing MOG-IgG Associated Disorders NCT06617962 · ClinicalTrials.gov ↗ · Myelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related Disorders	Observational	Recruiting	2024-11	China
Improved Sensitivity Detection of Serum HBsAg and HBsAg Reversion NCT06550622 · ClinicalTrials.gov ↗ · Hepatitis B, Chronic	Observational	Recruiting	2024-08	China
Study of Myasthenic Crisis in China NCT04837625 · ClinicalTrials.gov ↗ · Myasthenia Gravis, Myasthenic Crisis	Observational	Recruiting	2020-10	China
OBINOTUZUMAB Versus Cyclophosphamide + Glucocorticoids in Primary Membranous Nephropathy(Blossom Study) NCT06781944 · ClinicalTrials.gov ↗ · Primary Membranous Nephropathy Drug: Obinutuzumab	Phase 3	Recruiting	2024-10	China
CHinese ischEmic Stroke Beyond 4.5 Hours With TeNecteplase Under Optimized Non-Contrast CT Selection NCT06994975 · ClinicalTrials.gov ↗ · Acute Ischemic Stroke	Phase 3	Recruiting	2025-11	China
Real World Study of Classic Infectious Disease NCT04020536 · ClinicalTrials.gov ↗ · Brucelloses, Epidemic Hemorrhagic Fever, Kala-Azar	Observational	Recruiting	2020-05	China
Study of Brain-Gut Function Reconstruction After Intersphincteric Resection for Ultra-Low Rectal Tumors NCT06082648 · ClinicalTrials.gov ↗ · Rectal Neoplasms	Not applicable	Recruiting	2023-06	China
Real-World Study of Enarodustat for Anemia in Non-Dialysis CKD Patients NCT07741279 · ClinicalTrials.gov ↗ · Anemia of Chronic Kidney Disease, CKD, Non-dialysis Chronic Kidney Disease Drug: Enarodustat	Observational	Recruiting	2025-03	China
Myasthenia Gravis Registry in China NCT06241521 · ClinicalTrials.gov ↗ · Myasthenia Gravis	Observational	Recruiting	2024-02	China
Identification and Molecular Characterisation of Urban-environmental Stress Patterns Affecting Mental Illness NCT07571226 · ClinicalTrials.gov ↗ · Major Depressive Disorder (MDD), Anxiety Disorder, Alcohol Use Disorder (AUD)	Observational	Recruiting	2026-04	China
A Prospective Study on Esophagogastrostomy by an Innovative Surgical Technique NCT06300879 · ClinicalTrials.gov ↗ · Gastric Cancer, Adenocarcinoma of Esophagogastric Junction	Not applicable	Recruiting	2024-01	China
Effect of Ketosteril on Sarcopenia in Patients With Chronic Kidney Disease NCT06329622 · ClinicalTrials.gov ↗ · Chronic Kidney Disease, Sarcopenia	Phase 3	Recruiting	2024-05	China
The National Registry Study For the Real-world Patients With Parkinsonian Disorders in China NCT03649503 · ClinicalTrials.gov ↗ · Parkinsonian Disorders	Observational	Recruiting	2018-10	China
PDO Based Drug Sensitive Test in R/M SGC NCT06686979 · ClinicalTrials.gov ↗ · Salivary Gland Cancers, Patient Derived Organoid, Drug Sensitive Test in Vitro	Observational	Recruiting	2025-03	China
Exploratory Study on the Treatment of Gout With Potassium Citrate Sustained-release Tablets NCT06966635 · ClinicalTrials.gov ↗ · Hyperuricemia or Gout, Nephrolithiasis Drug: Sodium bicarbonate	Phase 4	Recruiting	2024-04	China
Real World Study of Chronic Viral Hepatitis NCT04025944 · ClinicalTrials.gov ↗ · Hepatitis, Chronic	Observational	Recruiting	2019-07	China
Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B NCT04896255 · ClinicalTrials.gov ↗ · Chronic Hepatitis b	Observational	Recruiting	2020-09	China
Exploratory Study on Infection and Immunosenescence Based on an Elderly Clinical Cohort NCT07672522 · ClinicalTrials.gov ↗ · Immunosenescence	Observational	Recruiting	2024-11	China
Active Screening of Latent Tuberculosis Infection in School Contacts of Active Tuberculosis Patients NCT06033807 · ClinicalTrials.gov ↗ · Tuberculosis, Latent Tuberculosis Infection	Observational	Recruiting	2023-09	China
Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB) NCT05081401 · ClinicalTrials.gov ↗ · Multidrug Resistant Tuberculosis, Rifampicin Resistant Tuberculosis, Pre-XDR-TB	Phase 3	Recruiting	2022-05	China
Neck Observation or Elective Neck Dissection in cT1N0M0 OSCC NCT06623266 · ClinicalTrials.gov ↗ · Oral Cancer, Lymph Node Metastasis	Not applicable	Recruiting	2024-09	China
A Real World Study of Paxlovid for the Treatment of Hospitalized Patients Confirmed With COVID-19 NCT05387369 · ClinicalTrials.gov ↗ · COVID-19 Drug: Paxlovid	Observational	Recruiting	2022-03	China
The Impact of Probiotic Intervention on the Gut Microbiota and Bowel Function NCT07369830 · ClinicalTrials.gov ↗ · Rectal Cancer Drug: Clostridium butyricum , Live	Not applicable	Recruiting	2025-10	China
Clinical Multimodal Surveillance of Respiratory Syndrome Pathogens NCT07694648 · ClinicalTrials.gov ↗ · Respiratory Tract Infections (RTI), Respiratory Syndrome, Acute, Severe, Acute Respiratory Infections (ARIs)	Observational	Recruiting	2025-09	China
Real-world Study Optimizing Nucleotide-analogues NCT05937178 · ClinicalTrials.gov ↗ · Hepatitis B, Chronic	Observational	Recruiting	2023-01	China
Sub-lobectomy for IDH Wild-type and TERT Promoter Mutant Glioblastoma NCT06368934 · ClinicalTrials.gov ↗ · Glioma, Glioblastoma	Not applicable	Not yet open	2024-04	China
RSV in Acute Respiratory Infection Surveillance Among Community-Dwelling Elderly Aged ≥50 Years in China NCT07075029 · ClinicalTrials.gov ↗ · Acute Respiratory Infections (ARIs)	Observational	Not yet open	2025-09	China
Vertebrobasilar Dolichoectasia Treatment With Amiloride NCT07634068 · ClinicalTrials.gov ↗ · Vertebrobasilar Dolichoectasia	Phase 2	Not yet open	2026-06	China
Evaluation of the Safety, Tolerability and Efficacy of Gene Therapy Drug for Late Onset Pompe Disease (LOPD) NCT06178432 · ClinicalTrials.gov ↗ · Pompe Disease (Late-onset)	Phase EARLY_PHASE1	Not yet open	2023-12	China
A Cohort Study on the Integrated Management of Chronic Kidney Disease NCT07712341 · ClinicalTrials.gov ↗ · Chronic Kidney Disease, Stage 5, Chronic Kidney Disease, Stage 4, Chronic Kidney Disease, Stage 3	Observational	Not yet open	2026-09	China
Vorasidenib Guided by AGX PET in Recurrent/Low-grade Glioma NCT07469735 · ClinicalTrials.gov ↗ · Glioma, Diffuse Glioma, Recurrent Gliomas	Not applicable	Not yet open	2026-04	China
Artificial Intelligence-driven Tuberculosis Landscape Analysis & Stratification Research NCT07611695 · ClinicalTrials.gov ↗ · Pulmonary Tuberculosis, Tuberculosis (TB), Tuberculosis Active	Observational	Not yet open	2026-06	China
Evaluating Immunomodulatory Interventions in Post-Acute Sequelae of SARS-CoV-2 InfEction NCT06597682 · ClinicalTrials.gov ↗ · Post-acute Sequelae of SARS-COV-2 Infection Drugs: Budesonide/Formoterol, Prednisone, Vitamin C	Not applicable	Not yet open	2025-03	China
Early Diagnosis and Recurrence Monitoring of Colorectal Cancer NCT06991452 · ClinicalTrials.gov ↗ · Colorectal Cancer	Observational	Not yet open	2025-05	China
Vertebrobasilar Dolichoectasia Treatment With Sirolimus NCT07634120 · ClinicalTrials.gov ↗ · Vertebrobasilar Dolichoectasia	Phase 2	Not yet open	2026-06	China
LED Therapy for Third Molar Surgery NCT06640439 · ClinicalTrials.gov ↗ · Molar, Third, Photobiomodulation, Photobiomodulation Therapy	Phase EARLY_PHASE1	Not yet open	2024-10	China
Safety and Efficacy of Edaravone Dexborneol Sublingual Tablets for Blood-Brain Barrier Dysfunction in CADASIL NCT07692399 · ClinicalTrials.gov ↗ · CADASIL Drug: Edaravone dexborneol sublingual	Phase 2	Not yet open	2026-07	China
Pegylated Interferon Alfa-2b in Reducing Relapse Rates After Nucleos(t)ide Analogue Withdrawal in HBeAg-negative CHB Patients with Low Level HBsAg NCT06900166 · ClinicalTrials.gov ↗ · Chronic Hepatitis B	Phase 4	Not yet open	2025-04	China
Chinese Multicenter Clinical Outcome Cohort Study of Myotonic Dystrophy Type 1 (C-DMCOS-DM1) NCT06101940 · ClinicalTrials.gov ↗ · Myotonic Dystrophy 1	Observational	By invitation	2021-08	China
Strategies for Proactive Health in People With Kidney Function Decline NCT07245186 · ClinicalTrials.gov ↗ · Renal Insufficiency,Chronic, Dietary Intake Patterns, Malnutrition	Observational	By invitation	2021-01	China
A Multicenter Phenotype-Genotype Analysis of LGMD Patients in China NCT04989751 · ClinicalTrials.gov ↗ · LGMD, LGMDR2, LGMDR1	Observational	By invitation	2021-07	China
Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BDLL Chinese Cohort NCT06649721 · ClinicalTrials.gov ↗ · Drug-resistant Tuberculosis, Pulmonary Tuberculosis, Rifampin-resistant Tuberculosis Drugs: Bedaquiline, Clofazimine, Delamanid	Phase 3	Active, closed	2024-11	China
Pre-operative Surgical Difficulty Stratification Using Predicted Tumor Perfusion and Consistency NCT06664190 · ClinicalTrials.gov ↗ · Pituitary Adenoma	Observational	Active, closed	2022-08	China
Postoperative Thrombosis Prevention in Patients With CD NCT04486859 · ClinicalTrials.gov ↗ · Cushing Disease, DVT, Pulmonary Embolism	Not applicable	Active, closed	2020-12	China
aSAH Treatment Based on Intraventricular ICP Monitoring: A Prospective, Multicenter, Randomized and Controlled Trial NCT06288659 · ClinicalTrials.gov ↗ · Aneurysmal Subarachnoid Hemorrhage, Intacranial Hypertension	Not applicable	Active, closed	2024-07	China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

Drugs in Huashan Hospital trials

24 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

Conditions in Huashan Hospital trials

108 conditions

Glioma4 Myasthenia Gravis4 Hepatitis B, Chronic3 Gastric Cancer3 Tuberculosis3Disorder of Consciousness2Acute Respiratory Infections (ARIs)2Respiratory Infectious Diseases2Acute Ischemic Stroke2Pulmonary Tuberculosis2Vertebrobasilar Dolichoectasia2Patient Derived Organoid2Drug Sensitive Test in Vitro2Chronic Kidney Disease2End Stage Liver DIsease1Complication1Cavernous Malformations1Intracerebral Hemorrhage1Brainstem Stroke1Glioblastoma1Spinal Cord Stimulation1Drug-resistant Tuberculosis1Rifampin-resistant Tuberculosis1Gastric Cancer Patients Undergoing Minimally Invasive Gastrectomy1

By trial register

Register	Trials	Recruiting
Clinical trials in China	75	55

A trial with sites in more than one country appears in each of those registers.

Other sponsors in Glioma

Sponsor	Trials
Tata Memorial Centre	5
The First Affiliated Hospital of Zhengzhou University	4
Cerenome	2
Nuvation Bio	2
The Third Affiliated hospital of Zhejiang Chinese Medical University	2
HighField Biopharmaceuticals Corporation	1
Beijing Neurosurgical Institute	1

Sponsors with the most current trials registered for this condition.

Questions about Huashan Hospital trials

How many clinical trials does Huashan Hospital sponsor?

Huashan Hospital is the lead sponsor of 75 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Huashan Hospital trials recruiting?

Yes. 55 of its 75 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Huashan Hospital testing?

Its current trials name 24 drugs and biologicals as interventions. The most frequent are Tumor vaccine (2), Atezolizumab (1), Bedaquiline (1), Budesonide/Formoterol (1) and Clofazimine (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.

Huashan Hospital clinical trials